Medix-Care UK Ltd

Contents

Statement of Financial Position	1 to 2
Notes to the Unaudited Financial Statements	3 to 9

Medix-Care UK Ltd

(Registration number: 13168404)
Statement of Financial Position as at 31 January 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	4	234,111	204,644
Current assets
Debtors	5	26,552	170,070
Cash at bank and in hand		4,815	151,057
		31,367	321,127
Creditors: Amounts falling due within one year	6	(233,553)	(329,272)
Net current liabilities		(202,186)	(8,145)
Total assets less current liabilities		31,925	196,499
Creditors: Amounts falling due after more than one year	6	-	(95,994)
Net assets		31,925	100,505
Capital and reserves
Called up share capital		200	200
Profit and loss account		31,725	100,305
Shareholders' funds		31,925	100,505

Medix-Care UK Ltd

(Registration number: 13168404)
Statement of Financial Position as at 31 January 2025 (continued)

For the financial year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Statement of Comprehensive Income.

Approved and authorised by the Board on 31 October 2025 and signed on its behalf by:
 

Mr W A Kressinger-Dunn Director

Medix-Care UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
173 Leeward House
Discovery Road
Plymouth
Devon
PL1 4PR
United Kingdom

Principal activity

The principal activity of the company is that of information technology consultancy activities.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the entity.

Going concern

The financial statements have been prepared on a going concern basis.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome.

Medix-Care UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

2	Accounting policies (continued)

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.

The company recognises revenue when: the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Property	2% straight line

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Medix-Care UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

2	Accounting policies (continued)

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. In the statement of financial position, bank overdrafts are shown within borrowing or current liabilities

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Costs include all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Medix-Care UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

2	Accounting policies (continued)

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the statement of comprehensive income over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Financial instruments

Recognition and measurement
A financial asset or a financial liability is recognised only when the company becomes party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 3).

4	Tangible assets

	Land and buildings £	Total £
Cost or valuation
At 1 February 2024	208,820	208,820
Additions	34,330	34,330
At 31 January 2025	243,150	243,150
Depreciation
At 1 February 2024	4,176	4,176
Charge for the year	4,863	4,863
At 31 January 2025	9,039	9,039
Carrying amount
At 31 January 2025	234,111	234,111
At 31 January 2024	204,644	204,644

Medix-Care UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

4	Tangible assets (continued)

Included within the net book value of land and buildings above is £234,111 (2024 - £204,644) in respect of freehold land and buildings.
 

5

Debtors

	Note	2025 £	2024 £
Amounts owed by related parties	9	-	154,220
Other debtors		17,497	655
Prepayments		3,839	15,195
Deferred tax assets		5,216	-
		26,552	170,070

6

Creditors

Creditors: amounts falling due within one year

	Note	2025 £	2024 £
Due within one year
Loans and borrowings	7	-	29,101
Amounts owed to group undertakings and undertakings in which the company has a participating interest	9	54,268	-
Taxation and social security		-	13,943
Accruals and deferred income		20,729	176,455
Other creditors		158,556	109,773
		233,553	329,272

 

Creditors include a loan from the directors' pension scheme which is secured of £29,974 (2024 - £29,101). The loan is being repaid in instalments and interest is being paid at a rate of 3% per annum.

Creditors: amounts falling due after more than one year

	Note	2025 £	2024 £
Due after one year
Loans and borrowings	7	-	95,994

 

Medix-Care UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

6	Creditors (continued)

Creditors include a loan from the directors' pension scheme which is secured of £9,973 (2024 - £95,994). The loan is being repaid in instalments and interest is being paid at a rate of 3% per annum

7	Loans and borrowings

Current loans and borrowings

	2025 £	2024 £
Other borrowings	-	29,101

8

Reserves

Profit and loss account:

This reserve records retained earnings and accumulated losses.

Medix-Care UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

9	Related party transactions

Transactions with directors

2025	At 1 February 2024 £	Advances to director £	Repayments by director £	At 31 January 2025 £
Mr W A Kressinger-Dunn
	(109,773)	29,810	(78,594)	(158,557)

2024	At 1 February 2023 £	Advances to director £	Repayments by director £	At 31 January 2024 £
Mr W A Kressinger-Dunn
	(102,716)	34,000	(41,057)	(109,773)

All directors loans are repayable on demand. No interest has been charged in respect of amounts owed to directors.

Loans to / (from) related parties

2025	Entities with joint control or significant influence £	Total £
At start of period	154,220	154,220
Repaid	(208,488)	(208,488)
At end of period	(54,268)	(54,268)

2024	Entities with joint control or significant influence £	Total £
At start of period	95,000	95,000
Advanced	59,220	59,220
At end of period	154,220	154,220